Categories of additional reimbursement for infection prevention | ARIP 1 (n = 210) | ARIP 2 (n = 245) | P-value | |
---|---|---|---|---|
Number of pharmacists | 1 | 0 (0.0%) | 0 (0.0%) | < 0.05 |
2–4 | 7 (3.3%) | 81 (33.1%) | ||
5–9 | 89 (42.4%) | 117 (47.8%) | ||
10–19 | 99 (47.1%) | 42 (17.1%) | ||
≥20 | 15 (7.1%) | 5 (2.0%) | ||
Introduction of the DPC system | DPC hospital | 174 (82.9%) | 105 (42.9%) | < 0.05 |
DPC preparatory hospital | 5 (2.4%) | 20 (8.2%) | ||
Non-DPC hospital | 30 (14.3%) | 115 (46.9%) | ||
NA | 1 (0.5%) | 5 (2.0%) | ||
Types of medical institutions | General hospitals | 199 (94.8%) | 217 (88.6%) | 0.0518 |
Care-mixa | 10 (4.8%) | 23 (9.4%) | ||
NA | 1 (0.5%) | 5 (2.0%) | ||
Pharmaceutical management and guidance to inpatients | Fairly well | 118 (56.2%) | 131 (53.5%) | 0.1700 |
Often | 59 (28.1%) | 65 (26.5%) | ||
Sometimes | 27 (12.9%) | 38 (15.5%) | ||
Not implemented | 0 (0.0%) | 6 (2.4%) | ||
NA | 6 (2.9%) | 5 (2.0%) | ||
Pharmaceutical management and guidance to pre-hospitalization patients | Fairly well | 61 (29.0%) | 88 (35.9%) | < 0.05 |
Often | 39 (18.6%) | 32 (13.1%) | ||
Sometimes | 62 (29.5%) | 54 (22.0%) | ||
Not implemented | 41 (19.5%) | 66 (26.9%) | ||
NA | 7 (3.3%) | 5 (2.0%) | ||
Pharmaceutical management and guidance to outpatients | Fairly well | 28 (13.3%) | 23 (9.4%) | < 0.05 |
Often | 28 (13.3%) | 19 (7.8%) | ||
Sometimes | 103 (49.0%) | 117 (47.8%) | ||
Not implemented | 42 (20.0%) | 80 (32.7%) | ||
NA | 9 (4.3%) | 6 (2.4%) | ||
Dispensing for inpatients (internal and external drugs) | Fairly well | 168 (80.0%) | 203 (82.9%) | 0.0715 |
Often | 22 (10.5%) | 33 (13.5%) | ||
Sometimes | 10 (4.8%) | 5 (2.0%) | ||
NA | 10 (4.8%) | 4 (1.6%) | ||
Dispensing for inpatients (injection drugs) | Fairly well | 154 (73.3%) | 183 (74.7%) | 0.4580 |
Often | 35 (16.7%) | 32 (13.1%) | ||
Sometimes | 13 (6.2%) | 19 (7.8%) | ||
Not implemented | 0 (0.0%) | 3 (1.2%) | ||
NA | 8 (3.8%) | 8 (3.3%) | ||
Dispensing and management guidance for outpatients (internal, external, and injection drugs) | Fairly well | 49 (23.3%) | 63 (25.7%) | 0.6859 |
Often | 28 (13.3%) | 21 (8.6%) | ||
Sometimes | 119 (56.7%) | 134 (54.7%) | ||
Not implemented | 1 (0.5%) | 19 (7.8%) | ||
NA | 13 (6.2%) | 8 (3.3%) | ||
Sterile drug processing of injection drugs for inpatients | Fairly well | 67 (31.9%) | 50 (20.4%) | < 0.05 |
Often | 51 (24.3%) | 34 (13.9%) | ||
Sometimes | 71 (33.8%) | 79 (32.2%) | ||
Not implemented | 13 (6.2%) | 76 (31.0%) | ||
NA | 8 (3.8%) | 6 (2.4%) | ||
Sterile drug processing of injection drugs for outpatients | Fairly well | 63 (30.0%) | 39 (15.9%) | < 0.05 |
Often | 37 (17.6%) | 21 (8.6%) | ||
Sometimes | 65 (31.0%) | 76 (31.0%) | ||
Not implemented | 37 (17.6%) | 102 (41.6%) | ||
NA | 8 (3.8%) | 7 (2.9%) | ||
Drug information management | Fairly well | 78 (37.1%) | 87 (35.5%) | 0.6859 |
Often | 66 (31.4%) | 88 (35.9%) | ||
Sometimes | 57 (27.1%) | 63 (25.7%) | ||
NA | 9 (4.3%) | 7 (2.9%) | ||
Therapeutic drug monitoring | Fairly well | 31 (14.8%) | 22 (9.0%) | < 0.05 |
Often | 47 (22.4%) | 27 (11.0%) | ||
Sometimes | 106 (50.5%) | 128 (52.2%) | ||
Not implemented | 18 (8.6%) | 61 (24.9%) | ||
NA | 8 (3.8%) | 7 (2.9%) | ||
Participation in cross-hospital medical teams (e.g., infection control team, antimicrobial stewardship team, and nutrition support team) | Fairly well | 82 (39.0%) | 73 (29.8%) | < 0.05 |
Often | 63 (30.0%) | 79 (32.2%) | ||
Sometimes | 51 (24.3%) | 79 (32.2%) | ||
Not implemented | 0 (0.0%) | 4 (1.6%) | ||
NA | 14 (6.7%) | 10 (4.1%) | ||
Education (includes pharmacy student education) and Research | Fairly well | 40 (19.0%) | 22 (9.0%) | < 0.05 |
Often | 40 (19.0%) | 32 (13.1%) | ||
Sometimes | 77 (36.7%) | 65 (26.5%) | ||
Not implemented | 45 (21.4%) | 113 (46.1%) | ||
NA | 8 (3.8%) | 13 (5.3%) | ||
Percentage of out-of-hospital prescriptions issued | ≥80% | 175 (83.3%) | 182 (74.3%) | 0.1369 |
60% to less than 80% | 6 (2.9%) | 6 (2.4%) | ||
40% to less than 60% | 2 (1.0%) | 3 (1.2%) | ||
< 40% | 22 (10.5%) | 45 (18.4%) | ||
NA | 5 (2.4%) | 9 (3.7%) |